Cooperative Agreement 72011520CA00003

This $287,878,180 cooperative agreement awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program is intended to scale up and improve the management of drug-resistant tuberculosis (DR-TB) in USAID-supported countries. The agreement will focus on expanding access to high-quality DR-TB treatment services and providing specialized technical assistance to enhance the quality of DR-TB programs at the country level. Key...

The Puerto Rico Department of Health (PRDOH) was awarded a $21,143 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The grant will support PRDOH's Puerto Rico Tuberculosis Central Program (PRTBCP) in its efforts to control and eventually eliminate tuberculosis in Puerto Rico and the U.S. Virgin Islands. Key activities will include enhancing TB surveillance, program planning and...

This Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) will provide $483,911 to the Colorado Department of Public Health & Environment (CDPHE) to support comprehensive tuberculosis (TB) elimination and laboratory services in Colorado. The key objectives are to: 1) Identify and fully treat persons with active TB disease; 2) Treat individuals diagnosed with latent TB infection; 3)...

This Project Grant award from the National Institutes of Health's John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) provides $108,237 to Mbarara University of Science and Technology in Uganda to develop and assess the feasibility of a diagnostic tool for post-tuberculosis (TB) lung disease that can be deployed in primary healthcare settings with limited diagnostic resources. The key products and services to be delivered under this award include: 1)...

This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) provides $815,916 to the Hawaii Department of Health to support comprehensive tuberculosis (TB) control and elimination efforts in the state of Hawaii. The key products and services to be delivered under this five-year award (1/1/2025 - 12/31/2029) include: TB screening, diagnosis, and treatment; contact investigation...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $8,150,118 Cooperative Agreement titled "STRENGTHENING PUBLIC HEALTH CAPACITY AND GUIDELINES TO IMPLEMENT HIV PROGRAMS" to the World Health Organization (WHO) under the Global Tuberculosis (TB) Federal Grant Program (CFDA 93.494). The 5-year award, running from September 2024 to September 2029, aims to support WHO's efforts to develop, evaluate, and implement evidence-based and innovative approaches to address the...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116), provides $3,393,862 to the New York City Department of Health and Mental Hygiene to support comprehensive tuberculosis (TB) prevention, control, and elimination efforts in New York City. Key products and services to be delivered under this 5-year award include: 1) Providing TB case management and...

The Department of State Bureau of African Affairs awarded a $110,000 project grant to Treatment Advocacy And Litera CY Campaign to implement the COMMUNITY LED MONITORING TO IMPROVE QUALITY OF HIV CARE IN ZAMBIA THROUGH CLIENT FEEDBACK project from March 1, 2022 to December 30, 2022. Under this award, Treatment Advocacy And Litera CY Campaign will work to improve HIV care quality in Zambia by establishing a community-led monitoring program that gathers client feedback. The grant is part of the...

This $109,704 Project Grant award from the National Institutes of Health's Fogarty International Center (CFDA 93.989 - International Research and Research Training) supports an implementation research project focused on integrating tuberculosis (TB) treatment into community pharmacies in Uganda to improve outcomes for people living with HIV/TB co-infection. The grantee, The Infectious Diseases Institute (IDI) in Kampala, Uganda, will: 1) explore barriers and facilitators to this intervention, 2)...

This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and pilot test an innovative, trauma-informed intervention approach to reduce overdose risk among justice-involved women re-entering the community from prison. The total award of $444,826 will be used to: 1) adapt the Trauma-Based Relational Intervention (TBRI) by developing prison group sessions and re-entry recovery support components...